How would you manage a transplant-eligible patient with DLBCL who relapsed 6-12 months following a CR1 to R-CHOP and then attained a CR2 to platinum-based salvage chemoimmunotherapy?  

How do you choose between CAR-T and autoSCT, for example? 

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Cleveland Clinic
Thanks for your reply, Dr. @Phillips. I also wonde...
Medical Oncologist at University of Maryland Cancer Center
If the goal is to offer salvage treatment in order...
Sign in or Register to read more

Answer from: at Community Practice

Answer from: Medical Oncologist at Community Practice